May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Retinal Toxicity Induced by the Administration of a Pan–Cyclin Dependent Kinase (cdk) Inhibitor in Albino Mice
Author Affiliations & Notes
  • O.G. Illanes
    Safety Sciences, Pfizer Inc., La Jolla, San Diego, CA
  • B. Jessen
    Safety Sciences, Pfizer Inc., La Jolla, San Diego, CA
  • L. Zwick
    MPI Research, Mattawan, MI
  • S. Anderson
    Safety Sciences, Pfizer Inc., La Jolla, San Diego, CA
  • M. Niesman
    Safety Sciences, Pfizer Inc., La Jolla, San Diego, CA
  • Footnotes
    Commercial Relationships  O.G. Illanes, Pfizer Inc., La Jolla E; B. Jessen, Pfizer Inc., La Jolla E; L. Zwick, MPI Research E; S. Anderson, Pfizer, Inc., La Jolla E; M. Niesman, Pfizer Inc., La Jolla E.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 1671. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      O.G. Illanes, B. Jessen, L. Zwick, S. Anderson, M. Niesman; Retinal Toxicity Induced by the Administration of a Pan–Cyclin Dependent Kinase (cdk) Inhibitor in Albino Mice . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1671.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: In this poster presentation we report unexpected retinal toxicity in the eyes of mice treated with a pan–cyclin–dependent kinase inhibitor.Cyclin–dependent kinases (Cdks) are core components of the cell cycle machinery that govern the transition between phases during cell cycle progression. Since deregulated cdk activity is a hallmark of malignancy, these enzymes are considered promising targets for cancer therapy. Methods:This particular CDK inhibitor was administered intravenously to CD–1 mice, at a dose of 50 mg/kg/day for 5 consecutive days. A group of treated mice were euthanized 24 hours after the last dose (study day 6), and a second group after a 21–day drug–free recovery period (study day 26). Results:Microscopic findings in the eyes of compound –treated mice were only detected after the recovery period. Retinal changes were characterized by a decrease in the thickness and cellularity of the outer layers of the retina, mainly the photoreceptor and outer nuclear cell layers. Although light microscopy examination of mice euthanized on day 6 revealed no morphologic evidence of retinal toxicity, apoptotic retinal cells were detected using a TUNEL assay (Apop Tag Kit, Intergen). Conclusions: The pathogenesis of the ocular lesions is unclear; however, retinal toxicity may be mechanistically driven since compound accumulation was detected within the eyes of treated animals and cdk5 is known to play a significant role in phototransduction and retinal development.

Keywords: retinal degenerations: cell biology • retina: distal (photoreceptors, horizontal cells, bipolar cells) • pathobiology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×